Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients

Abstract

Background:

Gray-matter (GM) atrophy is strongly predictive of cognitive impairment in multiple sclerosis (MS) patients. The thalamus is the region where the atrophy/cognition correlation is most robust. However, few studies have assessed diffusion tensor imaging (DTI) metrics within the thalamus.

Objective:

This study was designed to determine if thalamus white matter DTI predicts cognitive impairment after accounting for the effects of volume loss.

Methods:

We enrolled 75 MS patients and 18 healthy controls undergoing 3T brain magnetic resonance imaging (MRI). Thalamus volumes were calculated on 3D T1 images. Voxelwise analyses of DTI metrics were performed within the thalamic white matter tracts. Neuropsychological (NP) testing, acquired using consensus standard methods, contributed measures of memory, cognitive processing speed and executive function.

Results:

All cognitive tests were significantly predicted (R ² =0.31, p<0.001) by thalamus volume after accounting for influence of demographics. Mean diffusivity was retained in regression models predicting all cognitive tests, adding from 7–13% of additional explained variance (p<0.02) after accounting for thalamus volume.

Conclusions:

We confirm the significant role of thalamus atrophy in MS-associated cognitive disorder, and further report that subtle thalamus pathology as detected by DTI adds incremental explained variance in predicting cognitive impairment.

Keywords

Multiple sclerosis thalamus cognitive impairment diffusion tensor imaging mean diffusivity

Get full access to this article

View all access options for this article.

References

Fisher

Lee

Nakamura

. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255–265.

Langdon

. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244–249.

Filippi

Rocca

Benedict

. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75: 2121–2128.

Benedict

Zivadinov

. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2011; 7: 332–342.

Batista

Zivadinov

Hoogs

. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259: 139–146.

Benedict

Ramasamy

Munschauer

. Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201–206.

Houtchens

Benedict

Killiany

. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69: 1213–1223.

Rovaris

Iannucci

Falautano

. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: An exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002; 195: 103–109.

Mesaros

Rocca

Kacar

. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology 2012; 78: 969–975.

10.

Rovaris

Agosta

Pagani

. Diffusion tensor MR imaging. Neuroimaging Clin N Am 2009; 19: 37–43.

11.

Oreja-Guevara

Rovaris

Iannucci

. Progressive gray matter damage in patients with relapsing–remitting multiple sclerosis: A longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol 2005; 62: 578–584.

12.

Cifelli

Arridge

Jezzard

. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650–653.

13.

Polman

Reingold

Edan

. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58: 840–846.

14.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Ann Neurol 1983; 13: 227–231.

15.

Zivadinov

Rudick

De Masi

. Effects of IV methylprednisolone on brain atrophy in relapsing–remitting MS. Neurology 2001; 57: 1239–1247.

16.

Smith

Zhang

Jenkinson

. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479–489.

17.

Patenaude

Smith

Kennedy

. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56: 907–922.

18.

Smith

Jenkinson

Johansen-Berg

. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487–1505.

19.

Benedict

RHB

Fischer

Archibald

. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin Neuropsychol 2002; 16: 381–397.

20.

Chiaravalloti

DeLuca

. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139–1151.

21.

Delis

Kramer

Kaplan

. California Verbal Learning Test: Adult version. San Antonio, Texas: Psychological Corporation, 2000.

22.

Benedict

RHB

Brief Visuospatial Memory Test - Revised: Professional manual. Odessa, Floriday: Psychological Assessment Resources, Inc., 1997.

23.

Smith

Symbol Digit Modalities Test (SDMT) manual (revised). Los Angeles: Western Psychological Services, 1982.

24.

Gronwall

. Paced auditory serial addition task: A measure of recovery from concussion. Perceptual and motor skills 1977; 44: 367–373.

25.

Delis

Kaplan

Kramer

. Delis-Kaplan executive function system. San Antonio, Texas: Psychological Corporation, 2001.

26.

Schmierer

Wheeler-Kingshott

Boulby

. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007; 35: 467–477.

27.

Rovaris

Judica

Ceccarelli

. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008; 255: 1209–1214.

28.

Sumowski

Chiaravalloti

Erlanger

. L-amphetamine improves memory in MS patients with objective memory impairment. Mult Scler 2011; 17(9): 1141–1145.

29.

Krupp

Christodoulou

Melville

. A multi-center randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology

30.

Henry

Shieh

Amirbekian

. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 2009; 282: 61–66.